newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results

●Q2 Revenue of $12.0 million; a $1.0M and 9% increase year-over-year ●Q2 Test volume up 12% year-over-year to record levels ●Q2 Cash collections of $11.0M; a $0.7M and 7% increase year-over-year ●Q2 Volume, Revenue, and